Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets artificial intelligence ("AI")-powered, MRI-guided, incision-free therap
(Financial Post, 2025-11-10T21:32:31Z)